Physician profile
Daniel Wang
NPI 1164956520
$11,998.00
in general payments reported to CMS, 2019-2025
43 companies · $2,126 in 2025
The $2,126 reported for 2025 was more than what 81% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,127 · 2023: $2,558 · 2024: $5,187 · 2025: $2,126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,542 · Travel and Lodging: $3,200 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $112 · Gift: $16.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,542.26 |
| Travel and Lodging | $3,200.18 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $111.79 |
| Gift | $16.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $3,121.71 | 2023-2024 | Axonics, Bulkamid |
| Boston Scientific Corporation | $1,828.15 | 2022-2025 | Ams 700, Axonics, Rezum Generator |
| Teleflex LLC | $1,393.48 | 2022-2025 | Urolift |
| Abbvie INC. | $590.48 | 2023-2025 | Botox |
| Janssen Biotech, INC. | $542.02 | 2023-2025 | Erleada, Akeega |
| Progenics Pharmaceuticals, INC. | $518.63 | 2023-2025 | Pylarify |
| Sumitomo Pharma America, INC. | $497.17 | 2023-2025 | Orgovyx, Gemtesa |
| Pfizer INC. | $462.98 | 2022-2025 | |
| Endo USA, INC. | $265.70 | 2024-2025 | Xiaflex, Aveed |
| Bayer Healthcare Pharmaceuticals INC. | $265.17 | 2022-2025 | |
| Medtronic, INC. | $241.03 | 2022-2025 | Interstim |
| Immunitybio, INC. | $177.43 | 2025 | |
| Accord Healthcare, INC. | $165.72 | 2023-2025 | |
| Tolmar, INC. | $152.35 | 2023-2025 | Jatenzo, Eligard |
| Astellas Pharma US INC | $148.33 | 2022-2025 | Xtandi |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $138.63 | 2022 | |
| Antares Pharma, INC. | $128.08 | 2023-2025 | Xyosted, Nocdurna, Tlando |
| Ferring Pharmaceuticals INC. | $124.09 | 2024-2025 | Adstiladrin |
| Novartis Pharmaceuticals Corporation | $109.35 | 2023-2025 | |
| Urogen Pharma, INC. | $105.17 | 2023-2025 | Jelmyto |
| Endo Pharmaceuticals INC. | $93.64 | 2023-2024 | Aveed, Xiaflex, Edex |
| Merck Sharp & Dohme LLC | $92.83 | 2022-2024 | Lynparza, Keytruda, Welireg |
| Dendreon Pharmaceuticals LLC | $80.99 | 2023-2025 | Provenge |
| Tempus Ai, INC | $78.22 | 2024 | Xt Cdx |
| Olympus America INC. | $67.04 | 2023-2025 | Itind System |
| Myriad Genetic Laboratories, INC. | $64.16 | 2024 | Prolaris |
| Lantheus Medical Imaging, INC. | $51.96 | 2024 | |
| Novo Nordisk INC | $50.69 | 2024 | Rivfloza |
| Tolmar Pharmaceuticals, INC. | $49.05 | 2022 | |
| Bioprotect Medical, INC. | $48.87 | 2025 | Bioprotect Balloon Implant System |
| Coloplast Corp | $48.73 | 2023-2025 | Porges Coloplast |
| Blue Earth Diagnostics | $47.10 | 2023-2024 | |
| Caris Mpi, INC. | $38.47 | 2025 | Mi Cancer Seek |
| Alexion Pharmaceuticals, INC. | $26.56 | 2022 | |
| Laborie Medical Technologies Corp. | $26.36 | 2025 | Endosheath Technology |
| Telix Pharmaceuticals | $24.78 | 2024 | Illuccix |
| Cook Medical LLC | $22.37 | 2025 | Litho 150 |
| Amgen INC. | $21.38 | 2023 | Prolia |
| Halozyme INC | $21.05 | 2023 | |
| Alnylam Pharmaceuticals INC. | $17.13 | 2023 | Givlaari |
| Hollister Incorporated | $17.09 | 2023 | Vapro, Infyna Chic |
| Myovant Sciences INC. | $17.02 | 2022 | |
| Genentech USA, INC. | $16.84 | 2024 | Vabysmo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.